GSTM1 and non-small cell lung carcinoma: Although a few studies have noted the correlation between GSTM1 and GSTT1 gene polymorphisms and platinum-based chemotherapy response in NSCLC patients [34–36], no previous studies have monitored the effects of these gene polymorphisms on chemotherapy toxicity.